rhodioloside has been researched along with transforming growth factor beta in 2 studies
| Studies (rhodioloside) | Trials (rhodioloside) | Recent Studies (post-2010) (rhodioloside) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
|---|---|---|---|---|---|
| 621 | 2 | 519 | 49,119 | 560 | 17,610 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, P; Lu, Z; Sun, M; Zhao, J; Zheng, L | 1 |
| Liao, S; Liu, H; Xie, B; Xu, D; Zhou, C; Zhou, H | 1 |
2 other study(ies) available for rhodioloside and transforming growth factor beta
| Article | Year |
|---|---|
Salidroside enhances proliferation and maintains phenotype of articular chondrocytes for autologous chondrocyte implantation (ACI) via TGF-β/Smad3 Signal.
Topics: Animals; Cartilage, Articular; Cell Proliferation; Cell Survival; Cell Transplantation; Chondrocytes; Collagen Type I; Extracellular Matrix; Glucosides; Phenols; Primary Cell Culture; Rats, Sprague-Dawley; Smad3 Protein; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transplantation, Autologous | 2020 |
Salidroside alleviates dexamethasone-induced inhibition of bone formation via transforming growth factor-beta/Smad2/3 signaling pathway.
Topics: Animals; Dexamethasone; Glucocorticoids; Osteoblasts; Osteogenesis; Osteoporosis; Rats; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta; Transforming Growth Factors; Zebrafish; Zebrafish Proteins | 2023 |